AgeReverse Expands U.S. Retail Reach With RESURGE Launch on OneLavi.com

AgeReverse's flagship RESURGE longevity supplement is now available on OneLavi.com, extending the Canadian company's U.S. distribution beyond Amazon and signaling its push into mainstream American retail.

Bay Area Metrowire Staff
••Healthcare
AgeReverse Expands U.S. Retail Reach With RESURGE Launch on OneLavi.com

AgeReverse, a Canadian longevity company focused on healthy aging and cellular vitality, has announced that its flagship RESURGE formulation is now available to U.S. consumers through OneLavi.com. The move marks another milestone in the company's expanding U.S. retail presence and reflects a deliberate strategy to build a broader distribution network across multiple retail and e-commerce channels.

The OneLavi launch follows the recent availability of RESURGE on Amazon, giving the brand a presence on two major American online marketplaces. For a company still building awareness in the crowded U.S. longevity market, securing shelf space on established retail destinations is a critical step toward reaching consumers who may not yet be familiar with the AgeReverse name.

"Expanding our availability through OneLavi is another important step in introducing AgeReverse to more consumers across the United States," said Kubi Turkmen, Founder and CEO of AgeReverse. "Our goal is to make RESURGE accessible through established retail destinations while continuing to build awareness of our comprehensive approach to healthy aging."

AgeReverse developed RESURGE around the scientific framework of the 12 Hallmarks of Aging, which describes interconnected biological processes associated with aging. Rather than emphasizing a single ingredient or isolated wellness benefit, the company designed its flagship formulation to bring together multiple ingredients in a simplified daily regimen. The 90-capsule formulation includes NMN, Resveratrol, Quercetin, Fisetin, CoQ10, Astragalus Extract, Hyaluronic Acid, Aronia Extract and Noni Berry.

Key features of RESURGE include a design built around the 12 Hallmarks of Aging concept, a combination of multiple ingredients associated with antioxidant support and everyday wellness, support for nutrient metabolism, cardiovascular health and immune function, and support for collagen formation, connective tissue development and joint health. The product also simplifies what the company describes as 12 or more individual products and 15 or more capsules per day into a three-capsule daily regimen. It is manufactured in GMP-certified facilities in Ontario, Canada using vegan capsules and is registered as a Natural Health Product with Health Canada under NPN 80130202.

The expansion onto OneLavi comes as AgeReverse continues developing its presence in the U.S. longevity and healthy aging market. The company recently participated in the ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida, where it introduced RESURGE and its broader product strategy during scheduled meetings with retail buyers across health, specialty, food, drug and mass retail channels.

Beyond RESURGE, AgeReverse is developing a range of products focused on both internal wellness and external skin aging. Its broader plans include biological age testing, daily skincare, professional aesthetic formulations and non-invasive mesotherapy technology.

"Our long-term strategy is about more than a single product or sales channel," Turkmen added. "We are building a complete range of healthy aging solutions while expanding the ways consumers can access the AgeReverse brand."

The OneLavi availability represents another step in that strategy, complementing the company's existing Amazon presence and its ongoing efforts to develop additional U.S. retail relationships. The announcement matters because it shows a smaller Canadian player attempting to compete in the fast-growing American longevity supplement category by stacking distribution channels and positioning its multi-ingredient formula as a convenience-driven alternative to taking a dozen separate products.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Blockchain Registration

QR Code for Blockchain Registration